Suven Life Sciences Ltd Annually Results

Gross Sales

6.66

11.69

13.54

11.84

13.48

Excise Duty

0

0

0

0

0

Net Sales

6.66

11.69

13.54

11.84

13.48

Other Operating Income

0

0

0

0

0

Other Income

10.9

28.59

14.45

5.32

7.75

Total Income

17.55

40.28

27.99

17.16

21.23

Total Expenditure

172.43

139.7

139.42

134.23

93.54

PBIDT

-154.88

-99.42

-111.44

-117.07

-72.31

Interest

0.05

0.16

0.29

0.53

0.82

PBDT

-154.92

-99.58

-111.72

-117.6

-73.13

Depreciation

5.82

6.5

6.54

4.39

4.35

Minority Interest Before NP

0

0

0

0

0

Tax

0

-1

0

0

0

Deferred Tax

0

0

0

0

-5.32

Reported Profit After Tax

-160.75

-105.08

-118.27

-122

-72.15

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-160.75

-105.08

-118.27

-122

-72.15

Extra-ordinary Items

0

7.46

6

3.72

0

Adjusted Profit After Extra-ordinary item

-160.75

-112.54

-124.27

-125.72

-72.15

EPS (Unit Curr.)

-7.37

-4.82

-6.63

-9.05

-5.67

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

21.81

21.81

21.81

14.54

12.73

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-2,325.52

-850.47

-823.04

-988.76

-536.42

PBDTM(%)

-2,326.12

-851.83

-825.11

-993.24

-542.5

PATM(%)

-2,413.66

-898.88

-873.48

-1,030.4

-535.23